Cargando…

2589. Legionella pneumonia in cancer patients: 12-year experience at MD Anderson Cancer Center 2009-2021

BACKGROUND: Legionella pneumonia (LP) is an uncommon, yet severe pneumonia in cancer patients, but its clinical features are scarcely studied in contemporary cohorts. Therefore, this study aimed to characterize the clinical manifestations, therapy, and outcomes of LP in contemporary cancer patients....

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuo, Takahiro, Wurster, Sebastian, Jiang, Ying, Tarrand, Jeffrey, Kontoyiannis, Dimitrios P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676948/ http://dx.doi.org/10.1093/ofid/ofad500.2204

Ejemplares similares

457 Actinomyces Infection in Hematologic and Solid Cancer Patients at the University of Texas MD Anderson Cancer Center in 1998-2014
por: Gutierrez, Andres, et al.
Publicado: (2014)

Culture-Documented Invasive Mold Infections at MD Anderson Cancer Center in Houston, Texas, Pre– and Post–Hurricane Harvey
por: Kontoyiannis, Dimitrios P, et al.
Publicado: (2019)

828. Do lung co-infections influence outcome in patients with hematological malignancies and culture-documented invasive pulmonary aspergillosis?
por: Matsuo, Takahiro, et al.
Publicado: (2023)

827. Adjunct terbinafine in patients with leukemia and invasive fusariosis with skin lesions: Discordance between responses of skin lesions and systemic outcomes
por: Matsuo, Takahiro, et al.
Publicado: (2023)

2589. Two Cases of Congenital Babesiosis
por: Hachey, Kevin, et al.
Publicado: (2019)

416. Culture-Documented Invasive Mold Infections (cIMIs) at MD Anderson Cancer Center (MDACC) in Houston, Texas Pre- and Post-Hurricane Harvey
por: Kontoyiannis, Dimitrios P, et al.
Publicado: (2018)

2114. Invasive fusariosis in the era of mold active azoles and molecular targeted chemotherapy: Increasing incidence and lack of improved outcomes
por: Matsuo, Takahiro, et al.
Publicado: (2022)

M.D. Anderson, Oncología /
Publicado: (2000)

M.D. Anderson Cancer Center, oncología quirúrgica /
Publicado: (2005)

Neoadjuvant treatment: the MD Anderson experience
por: Hortobagyi, GN
Publicado: (2005)

Drug-Resistant Candida glabrata Infection in Cancer Patients
por: Farmakiotis, Dimitrios, et al.
Publicado: (2014)

Cardiometabolic healthcare for men with prostate cancer: an MD Anderson Cancer Center experience
por: Hahn, Andrew W., et al.
Publicado: (2023)

Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer
por: Axell-House, Dierdre B., et al.
Publicado: (2021)

482. The modern face of esophageal candidiasis (EC) in an oncology center: Analysis of 323 cancer patients with EC
por: Matsuo, Takahiro, et al.
Publicado: (2022)

Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience
por: Conter, Henry J., et al.
Publicado: (2014)

Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis
por: Wurster, Sebastian, et al.
Publicado: (2022)

Making Cancer History: Disease and Discovery at the University of Texas M.D. Anderson Cancer Center
por: Hyland, Callen
Publicado: (2010)

Evolution in Surgical Management of Breast Cancer-related Lymphedema: The MD Anderson Cancer Center Experience
por: Chang, Edward I., et al.
Publicado: (2020)

A longitudinal study of the Swedish MD Anderson Dysphagia Inventory in patients with oral cancer
por: Tuomi, Lisa, et al.
Publicado: (2020)

ETMR-04. EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES: THE MD ANDERSON CANCER CENTER EXPERIENCE
por: Gupta, Sumit, et al.
Publicado: (2020)

Obituary Notice of Thomas Anderson, M.D., F.L.S.
Publicado: (1870)

Book Reviews: Making Cancer History: Disease and Discovery at the University of Texas MD Anderson Cancer Center
por: Barnes, Emm
Publicado: (2011)

Validity and Reliability of the Korean Version of the MD Anderson Dysphagia Inventory for Head and Neck Cancer Patients
por: Kwon, Chan-Hyuk, et al.
Publicado: (2013)

DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes
por: Kuerer, Henry M., et al.
Publicado: (2017)

Hepatotoxicity with Vismodegib: An MD Anderson Cancer Center and Research on Adverse Drug Events and Reports Project
por: Edwards, Beatrice J., et al.
Publicado: (2017)

Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience
por: Tarek, Nidale, et al.
Publicado: (2020)

Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting
por: Kamal, Mona, et al.
Publicado: (2022)

Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA
por: Jung, Dong Sik, et al.
Publicado: (2015)

Analyzing 2,589 child neurology telehealth encounters necessitated by the COVID-19 pandemic
por: Rametta, Salvatore C., et al.
Publicado: (2020)

PB2589: EFFICACY AND SAFETY OF ABCD IN THE TREATMENT OF INVASIVE ASPERGILLOSIS IN PATIENTS WITH HEMATOLOGIC DISEASES
por: Pang, Aiming, et al.
Publicado: (2023)

1551. Cat Scratch Disease as a Mimicker of Malignancy: Rare and Elusive
por: Dhal, Udit, et al.
Publicado: (2020)

Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory
por: Mendoza, Tito, et al.
Publicado: (2020)

Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience
por: Tzeng, Ching-Wei D., et al.
Publicado: (2020)

Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center
por: Vo, Henry Hiep, et al.
Publicado: (2022)

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience
por: Nardo, Mirella, et al.
Publicado: (2023)

In Memoriam: Roger Yates Anderson (1927–2021)
por: Menking, Kirsten
Publicado: (2021)

Correction to Lancet Digit Health 2021; published online Aug 17. https://doi.org/10.1016/S2589-7500(21)00133-3
Publicado: (2021)

Review of Immune-Related Adverse Events in Prostate Cancer Patients Treated with Ipilimumab: MD Anderson Experience
por: Gao, Jianjun, et al.
Publicado: (2015)

EPEN-10. SPINAL MYXOPAPILLARY EPENDYMOMA AND METHYLATION-PROFILING: THE MD ANDERSON CANCER CENTER (MDACC) EXPERIENCE
por: Gupta, Sumit, et al.
Publicado: (2020)

Clinical characteristics and outcomes of phase I cancer patients with CCNE1 amplification: MD Anderson experiences
por: Yao, Shuyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q4uiegpvs0sk9fqjjt3m660tl7